A detailed history of Canandaigua National Corp transactions in Pfizer Inc stock. As of the latest transaction made, Canandaigua National Corp holds 203,735 shares of PFE stock, worth $5.59 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares
203,735
Previous 196,752 3.55%
Holding current value
$5.59 Million
Previous $8.61 Million 21.24%
% of portfolio
1.77%
Previous 1.53%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $291,540 - $380,573
6,983 Added 3.55%
203,735 $10.4 Million
Q3 2022

Oct 05, 2022

BUY
$43.76 - $53.42 $139,550 - $170,356
3,189 Added 1.65%
196,752 $8.61 Million
Q2 2022

Jul 05, 2022

SELL
$46.53 - $55.17 $95,246 - $112,932
-2,047 Reduced 1.05%
193,563 $10.1 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $2.12 Million - $2.62 Million
46,253 Added 30.97%
195,610 $10.1 Million
Q4 2021

Jan 04, 2022

SELL
$41.32 - $61.25 $16,693 - $24,745
-404 Reduced 0.27%
149,357 $8.82 Million
Q3 2021

Oct 04, 2021

SELL
$39.25 - $50.42 $161,474 - $207,427
-4,114 Reduced 2.67%
149,761 $6.44 Million
Q2 2021

Jul 06, 2021

SELL
$35.91 - $40.68 $80,115 - $90,757
-2,231 Reduced 1.43%
153,875 $6.03 Million
Q1 2021

Apr 05, 2021

SELL
$33.49 - $37.77 $155,561 - $175,441
-4,645 Reduced 2.89%
156,106 $5.66 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $912,325 - $1.16 Million
-27,258 Reduced 14.5%
160,751 $5.92 Million
Q3 2020

Oct 19, 2020

SELL
$31.75 - $37.25 $540,099 - $633,659
-17,011 Reduced 8.3%
188,009 $6.9 Million
Q2 2020

Jul 07, 2020

BUY
$30.12 - $36.54 $6.18 Million - $7.49 Million
205,020 New
205,020 $6.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Canandaigua National Corp Portfolio

Follow Canandaigua National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.